PETMED EXPRESS INC (PETS) Stock Price & Overview

NASDAQ:PETS • US7163821066

Current stock price

2.42 USD
-0.06 (-2.42%)
At close:
2.41 USD
-0.01 (-0.41%)
After Hours:

The current stock price of PETS is 2.42 USD. Today PETS is down by -2.42%. In the past month the price decreased by -17.97%. In the past year, price decreased by -43.06%.

PETS Key Statistics

52-Week Range1.57 - 4.32
Current PETS stock price positioned within its 52-week range.
1-Month Range2.34 - 2.97
Current PETS stock price positioned within its 1-month range.
Market Cap
51.788M
P/E
N/A
Fwd P/E
237.25
EPS (TTM)
-0.30
Dividend Yield
N/A

PETS Stock Performance

Today
-2.42%
1 Week
-1.63%
1 Month
-17.97%
3 Months
-32.78%
Longer-term
6 Months -11.36%
1 Year -43.06%
2 Years -49.48%
3 Years -85.10%
5 Years -93.12%
10 Years -86.49%

PETS Stock Chart

PETMED EXPRESS INC / PETS Daily stock chart

PETS Technical Analysis

ChartMill assigns a technical rating of 0 / 10 to PETS. When comparing the yearly performance of all stocks, PETS is a bad performer in the overall market: 91.17% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

PETS Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to PETS. PETS scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

PETS Earnings

Next Earnings DateJun 15, 2026
Last Earnings DateFeb 9, 2026
PeriodQ3 / 2026
EPS Reported
Revenue Reported
EPS Surprise %
Revenue Surprise -26.24%

PETS Forecast & Estimates

6 analysts have analysed PETS and the average price target is 2.81 USD. This implies a price increase of 15.91% is expected in the next year compared to the current price of 2.42.

For the next year, analysts expect an EPS growth of 26.23% and a revenue growth -14.05% for PETS


Analysts
Analysts40
Price Target2.81 (16.12%)
EPS Next Y26.23%
Revenue Next Year-14.05%

PETS Groups

Sector & Classification

PETS Financial Highlights

Over the last trailing twelve months PETS reported a non-GAAP Earnings per Share(EPS) of -0.3. The EPS increased by 22% compared to the year before.


Income Statements
Revenue(TTM)182.67M
Net Income(TTM)-64.87M
Industry RankSector Rank
PM (TTM) N/A
ROA -73.74%
ROE -197.98%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%-1364.43%
Sales Q2Q%-23.26%
EPS 1Y (TTM)22%
Revenue 1Y (TTM)-26.05%

PETS Ownership

Ownership
Inst Owners35.77%
Shares21.40M
Float14.87M
Ins Owners2.8%
Short Float %7.16%
Short Ratio6.42

About PETS

Company Profile

PETS logo image PetMed Express, Inc. markets prescription and non-prescription pet medications, health products and supplies for dogs and cats. The company is headquartered in Delray Beach, Florida and currently employs 173 full-time employees. The company went IPO on 2000-04-06. The firm is an online provider of prescription and non-prescription medications, food, supplements, and supplies and has veterinary and pet insurance service partnerships for dogs, cats, and horses. The company markets and sells directly to consumers through their Websites, toll-free numbers, and employer benefit partnerships. Its product line contains over 15,000 SKUs of pet medications, health products, foods, and supplies. The firm offers various pet supplies, including beds, crates, stairs and other pet supplies. Its products include Prescription Medications (Rx), Non-Prescription Medications (OTC) and supplies, Pet Foods, Private Label and Holistic Wellness Services. Rx includes heartworm and flea and ticks preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.

Company Info

IPO: 2000-04-06

PETMED EXPRESS INC

420 South Congress Avenue

Delray Beach FLORIDA 33445 US

CEO: Menderes Akdag

Employees: 287

PETS Company Website

PETS Investor Relations

Phone: 15614264444

PETMED EXPRESS INC / PETS FAQ

What does PETMED EXPRESS INC do?

PetMed Express, Inc. markets prescription and non-prescription pet medications, health products and supplies for dogs and cats. The company is headquartered in Delray Beach, Florida and currently employs 173 full-time employees. The company went IPO on 2000-04-06. The firm is an online provider of prescription and non-prescription medications, food, supplements, and supplies and has veterinary and pet insurance service partnerships for dogs, cats, and horses. The company markets and sells directly to consumers through their Websites, toll-free numbers, and employer benefit partnerships. Its product line contains over 15,000 SKUs of pet medications, health products, foods, and supplies. The firm offers various pet supplies, including beds, crates, stairs and other pet supplies. Its products include Prescription Medications (Rx), Non-Prescription Medications (OTC) and supplies, Pet Foods, Private Label and Holistic Wellness Services. Rx includes heartworm and flea and ticks preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.


What is the current price of PETS stock?

The current stock price of PETS is 2.42 USD. The price decreased by -2.42% in the last trading session.


Does PETS stock pay dividends?

PETS does not pay a dividend.


What is the ChartMill rating of PETMED EXPRESS INC stock?

PETS has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.


Can you provide the upcoming dividend date for PETMED EXPRESS INC?

The next ex-dividend date for PETMED EXPRESS INC (PETS) is August 11, 2023.


Is PETMED EXPRESS INC (PETS) stock a good buy?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on PETS.


Can you provide the upcoming earnings date for PETMED EXPRESS INC?

PETMED EXPRESS INC (PETS) will report earnings on 2026-06-15, after the market close.